Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Mouse embryonic stem cells differentiated into motor neurons after a GFP tag was inserted in frame with the motor-neuron-specific transcription factor HB9, using CRISPR/Cas9 engineering. The Patent ...

A novel gene therapy approach that repairs autologous, long-lasting T cells ex vivo may offer hope to patients with familial hemophagocytic lymphohistiocytosis (FHL), an inherited immune deficiency ...

The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year later in Europe for ...